FDA Inspection 739306 — Meda Pharmaceuticals Inc.
The FDA completed an inspection of Meda Pharmaceuticals Inc. on Aug 5, 2011 in Somerset, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 5, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somerset, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)